Cyclopropylfentanyl

Cyclopropylfentanyl is a potent synthetic opioid that is an analog of fentanyl. It is a relatively new drug, having first been identified in June 2017. It is considered to be a designer drug, meaning it is created in a laboratory to mimic the effects of other drugs, in this case, fentanyl.

Chemical Structure[edit | edit source]

Cyclopropylfentanyl is a fentanyl analog, meaning it shares a similar chemical structure with fentanyl. The primary difference is the addition of a cyclopropyl group to the phenethyl moiety of fentanyl. This modification results in a drug that is approximately 1.5 times more potent than fentanyl.

Effects[edit | edit source]

Like other opioids, cyclopropylfentanyl produces effects such as euphoria, pain relief, and sedation. However, due to its high potency, it also carries a significant risk of overdose, which can result in respiratory depression, unconsciousness, and death.

Legal Status[edit | edit source]

Cyclopropylfentanyl is a controlled substance in many countries, including the United States, where it is classified as a Schedule I drug under the Controlled Substances Act. This means it has a high potential for abuse and no accepted medical use.

Health Risks[edit | edit source]

The health risks associated with cyclopropylfentanyl are similar to those of other opioids. These include addiction, respiratory depression, and overdose. Due to its high potency, even small amounts can be lethal.

Treatment[edit | edit source]

Treatment for cyclopropylfentanyl addiction is similar to that for other opioid addictions. This typically involves a combination of medication-assisted treatment (using drugs like methadone or buprenorphine) and behavioral therapy.